FDA releases discussion paper on distributed and point-of-care manufacturing
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesNorth AmericaPharmaceuticalsProduct Lifecycle